Detalles de la búsqueda
1.
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China Study.
Int J Cancer
; 148(9): 2313-2320, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33231285
2.
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.
Lung Cancer
; 135: 188-195, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446994
3.
Five-Year Overall Survival for Patients With Advanced NonâSmall-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
J Clin Oncol
; 37(28): 2518-2527, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154919
4.
Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program.
J Immunother
; 40(9): 334-340, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29028788
Resultados
1 -
4
de 4
1
Próxima >
>>